Varex Imaging

Varex Imaging Corp. engages in the design, manufacture, and sale of imaging components. It operates through the Medical and Industrial segments. The Medical segment delivers and services x-ray imaging components, including X-ray tubes, digital detectors, high voltage connectors, image-processing software and workstations, and three-dimensional reconstruction software. The Industrial segment offers x-ray imaging products for use in security, and nondestructive testing and inspection applications. The company was founded in July 2016 and is headquartered in Salt Lake City, UT.

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Varex Imaging meets Q1 expectations amidst gross margin challenges

Varex Imaging's Q1 performance met expectations, with revenue impacted by a less favorable product mix. The company faces challenges from cautious customer behavior and gross margin pressures but sees opportunities in the healthcare market, particularly in China.

Varex Imaging excels in Q2, plans expansion amid supply challenges

Varex Imaging delivered strong Q2 results, driven by robust performance in the Industrial segment and innovative projects in Medical and Industrial segments.
While facing supply chain challenges, the company aims to invest in expanding manufacturing capacity to address demand and ensure operational resilience.
With a positive outlook for fiscal 2023 and a focus on cost management, Varex is poised for continued growth and market leadership in the imaging industry.

Varex Imaging achieves record revenue in Q3 2023 earnings

Varex Imaging delivered a robust performance in Q3 2023, marked by record revenue, improved margins, and strong segment growth.
While facing supply chain and market challenges, the company remains optimistic about sustained growth and profitability.
Strategic focus on new products, margin enhancement, and key segment expansion positions Varex well for future success.

Varex Imaging posts strong Q4 results, eyes growth opportunities

Varex Imaging reports solid Q4 performance with revenue driven by Industrial segment. Challenges include decline in Medical segment revenue and anticipated revenue decrease in Q1 FY 2024. Company focuses on growth opportunities in photon counting technology, India expansion, and new product introductions.

Varex Imaging meets Q1 expectations, focuses on photon counting growth

Varex Imaging's Q1 performance met expectations, with revenue at $190 million and a focus on new product development in photon counting technology.
While facing challenges in certain modalities and markets, the company showcased strength in global Industrial sales and employee pride.
Opportunities lie in the photon counting technology for CT, revenue growth expectations for Q2, and stable operational environment post-supply chain issues.
Management's forward-looking approach towards customer successes and technology advancements positions Varex Imaging for future growth and market expansion.

Varex Imaging faces revenue challenges in China, eyes tech growth

Varex Imaging's Q2 performance reflected mixed results with revenue, gross margin, and EPS figures. While facing challenges from soft demand in China, the company is focusing on leveraging photon-counting technology for future growth opportunities.

Varex Imaging meets Q3 revenue expectations amidst market challenges

Varex Imaging's Q3 performance was solid, with strengths in cargo inspection products and financial stability.
Challenges in China and the Medical segment require strategic focus for sustained growth.
Opportunities lie in market improvements, managing demand effectively, and exploring new growth avenues.

Varex Imaging reports resilient Q4 performance and outlines growth strategies

Varex Imaging's Q4 performance showcased revenue resilience in the industrial segment but faced challenges in medical segment revenue.
The company's strategic focus on innovation and expansion presents growth opportunities in dynamic markets.
Balancing revenue diversification, margin maintenance, and operational efficiency will be key for future success.
Anticipated revenue growth in Q1 2025 with a range of $195-215 million and varied EPS expectations.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Varex Imaging Corp. engages in the design, manufacture, and sale of imaging components. It operates through the Medical and Industrial segments. The Medical segment delivers and services x-ray imaging components, including X-ray tubes, digital detectors, high voltage connectors, image-processing software and workstations, and three-dimensional reconstruction software. The Industrial segment offers x-ray imaging products for use in security, and nondestructive testing and inspection applications. The company was founded in 2016 and is headquartered in Salt Lake City, UT.

As of late, it has definitely been a great time to be an investor in Varex Imaging (VREX).

Varex Imaging's (VREX) Shares March Higher, Can It Continue?

Varex Imaging Corporation (VREX) CEO Sunny Sanyal on Q1 2021 Results - Earnings Call Transcript

VAREX IMAGING (VREX) delivered earnings and revenue surprises of 300.00% and 2.99%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?

VAREX IMAGING (VREX) Q1 Earnings and Revenues Surpass Estimates

Shares of Varex Imaging (NASDAQ:VREX) moved higher by 3.5% in after-market trading after the company reported Q1 results. Quarterly Results Earnings per share decreased 61.90% year over year to $0.08, which beat the estimate of ($0.03).

Recap: Varex Imaging Q1 Earnings

SALT LAKE CITY--(BUSINESS WIRE)--Varex Imaging Corporation (Nasdaq: VREX) today announced its unaudited financial results for the first quarter of fiscal year 2021. 1QFY21 Summary Revenues $177 million GAAP gross margin 32% | Non-GAAP gross margin* 34% GAAP operating expense $51 million | Non-GAAP operating expense* $46 million GAAP operating margin 3% | Non-GAAP operating margin* 8% GAAP net earnings $(0.16) per diluted share | Non-GAAP net earnings* $0.08 per diluted share “Our financial resu

Varex Announces Financial Results for First Quarter Fiscal Year 2021

Varex Imaging (NASDAQ:VREX) unveils its next round of earnings this Thursday, February 04. Get prepared with Benzinga's ultimate preview for Varex Imaging's Q1 earnings.

Earnings Outlook for Varex Imaging

SALT LAKE CITY--(BUSINESS WIRE)--Varex Imaging Corporation (Nasdaq: VREX) today announced that it will report unaudited financial results for the first quarter of fiscal year 2021 following the close of regular trading on Thursday, February 4, 2021. The earnings news release will be followed by a conference call at 3:00 pm Mountain Time that day. This call will be webcast live and can be accessed at the company's website at investors.vareximaging.com. Investors can also access this conference c

Varex Schedules First Quarter Fiscal Year 2021 Earnings Release and Conference Call

SALT LAKE CITY--(BUSINESS WIRE)--Varex Imaging Corporation (Nasdaq: VREX) announced today that it is scheduled to make presentations at two upcoming virtual investor conferences. CJS Securities 21st Annual New Ideas for the New Year Conference Varex will be presenting on Wednesday, January 13, 2021 at 1:35 pm ET. The listen-only webcast link is: https://wsw.com/webcast/cjs2/vrex/1625178 Sidoti Winter 2021 Investor Conference Varex will be presenting on Thursday, January 14, 2021 at 11:30 am ET.

Varex to Present at Two Virtual Investor Conferences

Anika Therapeutics

Laureate Education

Nuance Communications

Just like selecting good and undervalued stocks on a regular basis can make you rich, identifying and proactively getting rid of toxic stocks is also crucial to maximizing portfolio returns.

Keep These 4 Toxic Stocks Away From Your Portfolio

Aramark

Alteryx

Cameco

Detecting toxic stocks and dumping them at the right time is crucial to safeguarding one's portfolio from big losses.

Dump These 4 Toxic Stocks Before It's Too Late

SALT LAKE CITY--(BUSINESS WIRE)--Varex Imaging Corporation (Nasdaq: VREX) will showcase its latest X-ray tubes and sources, digital detectors, connect and control devices and software solutions at the 106th Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA). RSNA 2020 has transitioned to a virtual conference format and will take place November 29 - December 5, 2020. In addition to Varex's existing X-ray imaging product portfolio, the company will highligh

Varex to Showcase New X-Ray Components at RSNA 2020 Virtual Exhibition

Varex Imaging Corporation (VREX) CEO Sunny Sanyal on Q4 2020 Results - Earnings Call Transcript

Shares of Varex Imaging (NASDAQ:VREX) increased 4.27% after the company reported Q4 results. Quarterly Results Earnings per share fell 108.70% year over year to ($0.04), which beat the estimate of ($0.10).

Recap: Varex Imaging Q4 Earnings

SALT LAKE CITY--(BUSINESS WIRE)--Varex Imaging Corporation (Nasdaq: VREX) today announced its unaudited financial results for the fourth quarter and fiscal year 2020. 4QFY20 Summary Revenues were $170 million GAAP gross margin was 27% | non-GAAP gross margin* was 28% GAAP operating expense was $58 million | non-GAAP operating expense* was $48 million GAAP operating margin was (8%) | non-GAAP operating margin* was 0% GAAP net loss was $0.66 per diluted share | non-GAAP net loss* was $0.04 per di

Varex Announces Financial Results for Fourth Quarter and Fiscal Year 2020

SALT LAKE CITY--(BUSINESS WIRE)--Varex Imaging Corporation (Nasdaq: VREX) today announced that it will report unaudited financial results for the fourth quarter and fiscal year 2020 following the close of regular trading on Tuesday, November 17, 2020. The earnings news release will be followed by a conference call at 3:00 pm Mountain Time that day. This call will be webcast live and can be accessed at the company's website at investors.vareximaging.com. Investors can also access this conference

Varex Schedules Fourth Quarter and Fiscal Year 2020 Earnings Release and Conference Call

SALT LAKE CITY--(BUSINESS WIRE)--Varex Imaging Corporation (Nasdaq: VREX) today announced it has closed its private offering (the “Offering”) of $300 million aggregate principal amount of 7.875% senior secured notes due 2027 (the “notes”) at an offering price of 100% of the principal amount thereof. Simultaneously, Varex entered into a senior secured asset-based revolving credit facility (the “ABL Credit Facility”) in an initial aggregate principal amount of up to $100 million. “We are pleased

Varex Announces Closing of Private Offering of $300 Million of Senior Secured Notes

SALT LAKE CITY--(BUSINESS WIRE)--Varex Imaging Corporation (Nasdaq: VREX) today announced it has priced a private offering (the “Offering”) of $300 million aggregate principal amount of 7.875% senior secured notes due 2027 (the “notes”) at an offering price of 100% of the principal amount thereof. Varex intends to use the net proceeds from the sale of the notes to pay in full all amounts outstanding under its existing credit facility, which includes its term loan and revolving credit facility,

Varex Announces Pricing of Private Offering of $300 Million of Senior Secured Notes

SALT LAKE CITY--(BUSINESS WIRE)--Varex Imaging Corporation (Nasdaq: VREX) today announced it has commenced a private offering (the “Offering”), subject to market and other conditions, of $300 million aggregate principal amount of senior secured notes due 2027 (the “notes”). Varex intends to use the net proceeds from the sale of the notes to pay in full all amounts outstanding under its existing credit facility, which includes its term loan and revolving credit facility, and for general corporat

Varex Announces Private Offering of $300 Million of Senior Secured Notes

SALT LAKE CITY--(BUSINESS WIRE)--Varex Imaging Corporation (Nasdaq: VREX) today announced that Timothy E. Guertin has been appointed to the company’s Board of Directors, effective September 2, 2020.

Varex Names Timothy E. Guertin to Board of Directors

Varex Imaging Corporation, best known for its X-ray tubes and imaging solutions, has seen its stock fall 60% year-to-date – decreasing from $30 at the beginning of the year to around $12 now, significantly underperforming the S&P500, which grew 5%. Why? Imaging companies, such as Varex.

40% Upside Possible For Varex Imaging Stock

Varex Imaging Corporation (VREX) CEO Sunny Sanyal on Q3 2020 Results - Earnings Call Transcript

VAREX IMAGING (VREX) delivered earnings and revenue surprises of -233.33% and -0.76%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?

VAREX IMAGING (VREX) Reports Q3 Loss, Misses Revenue Estimates

Shares of Varex Imaging (NASDAQ:VREX) fell 3.44% in after-market trading after the company reported Q3 results.

Varex Imaging: Q3 Earnings Insights

SALT LAKE CITY--(BUSINESS WIRE)--Varex Imaging Corporation (Nasdaq: VREX) today announced its unaudited financial results for the third quarter of fiscal year 2020. 3QFY20 Summary Revenues were $171 million GAAP gross margin was 15% | non-GAAP gross margin* was 26% GAAP operating earnings margin was (15.7)% | non-GAAP operating earnings margin* was (0.7)% GAAP net loss was ($0.73) per diluted share | non-GAAP net loss* was ($0.20) per diluted share “During the third quarter of fiscal year 2020,

Varex Announces Financial Results for Third Quarter of Fiscal Year 2020

On Wednesday, August 12, Varex Imaging (NASDAQ: VREX) will release its latest earnings report.

News for Varex Imaging Stock (VREX)